Market Research Reports

Interventional Cardiology Devices Market: (By Types: Stents, Catheters, PTCA Balloons, PTCA Guidewires, Imaging Systems and Others) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

118pages
Published Date: 2015-06-16
 

Description



Interventional cardiology devices are minimally invasive devices used in the detection and treatment of coronary artery disease. This report on interventional cardiology devices studies the current and future prospects of the market globally. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides the overall information and data analysis of the global interventional cardiology devices market with respect to the leading market segments based on type of device, technique, and geography.

The market overview section of the report comprises qualitative analysis of the overall interventional cardiology devices market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as value chain analysis, regulatory framework, market attractiveness analysis by geography and competitive landscape by key players has also been provided. Value chain analysis includes the study of major steps involved in the production and distribution of interventional cardiology devices. Regulatory framework includes the study of different regulatory norms and procedures that regulate the approval and commercialization of interventional cardiology devices and techniques. The market attractiveness analysis is provided in order to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

The global interventional cardiology devices market has been segmented on the basis of device type, technique, and geography. Based on device type, the interventional cardiology devices market has been categorized into five major segments: stents, catheters, percutaneous transluminal coronary angioplasty (PTCA) balloons, percutaneous transluminal coronary angioplasty (PTCA) guide wires, and other accessories. Stents have been further categorized into three sub-segments: bare metal stents, drug eluting stents, and bio-absorbable stents. Catheters have been further categorized into angiography catheters, intravascular ultrasound (IVUS) catheters, percutaneous transluminal coronary angioplasty (PTCA) guiding catheters, and pulmonary artery catheters. Percutaneous transluminal coronary angioplasty (PTCA) balloons have been subdivided into normal balloons, cutting balloons, scoring balloons, and drug eluting balloons. The imaging systems interventional cardiology devices market is subdivided into intravascular ultrasound (IVUS) systems, fractional flow reserve (FFR) systems, and optical coherence tomography (OCT) systems. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

Geographically, the interventional cardiology devices market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia-Pacific. Latin America comprises Brazil, Mexico, and Rest of Latin America. Middle East and North Africa comprises Saudi Arabia, the United Arab Emirates and Rest of MENA. The recommendations section included in the report would assist existing players to expanding their market share and new companies in establishing their presence in the interventional cardiology devices market. The report also profiles major players in the interventional cardiology devices market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation.

The global Interventional Cardiology Devices market is segmented as follows:

Global Interventional Cardiology Devices Market, by Device Type
  • Stents
    • Bare Metal Stents
    • Drug-Eluting Stents
    • Bio-absorbable Stents
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • Pulmonary Artery Catheters
    • Intravascular ultrasound (IVUS) Catheters
  • PTCA Balloons
    • Normal Balloons
    • Cutting Balloons
    • Scoring Balloons
    • Drug-eluting Balloons
  • Imaging Systems
    • IVUS (intravascular ultrasound)
    • FFR (Fractional Flow Reserve)
    • OCT (Optical Coherence Tomography)
  • Percutaneous Transluminal Coronary Angioplasty Guidewires
  • Others
Global Interventional Cardiology Devices Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East North Africa (MENA)
    • Saudi Arabia
    • United Arab Emirates
    • Rest of MENA
  • Rest of the World (RoW)

Table of Contents



Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
       1.3.1 Secondary Research
       1.3.2 Primary Research
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Interventional Cardiology (IC) Devices Market (2013 & 2022)
2.2 Global Interventional Cardiology Devices Market Revenue, by Types, 2013 (USD Million)
2.3 Comparative Analysis: Global Interventional Cardiology Devices Market Revenue, by Geography, 2013 & 2022 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
       3.2.1 Increasing prevalence of coronary artery disease
       3.2.2 Rise in global obesity rate along with aging population likely to trigger the number of PCIs
                3.2.2.1 The absolute number of coronary heart disease deaths by decade of age, 2010-2040
       3.2.3 Penetration of new imaging technology greatly enhances PCI guidance and diagnosis rate
       3.2.4 Rising demand for minimally invasive surgeries
3.3 Market Restraints
       3.3.1 Decrease in average selling price
       3.3.2 Lack of efficient reimbursement system in emerging economies
       3.3.3 Slow growth in number of PCIs
3.4 Opportunities
       3.4.1 Advent of bio-absorbable stents projected as a viable alternative to drug eluting stents
       3.4.2 Emerging nations
3.5 Porter’s Five Force Analysis of the Global Interventional Cardiology Devices Market
       3.5.1 Bargaining power of suppliers
       3.5.2 Bargaining power of buyers
       3.5.3 Threat of substitutes
       3.5.4 Threat of new entrants
       3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Interventional Cardiology Devices Market, by Geography
3.7 Competitive Landscape
       3.7.1 Market Share Analysis: Global Interventional Cardiology Devices Market, 2014 (Value %)
3.8 Regulatory Framework
3.9 Value Chain Analysis

Chapter 4 Global Interventional Cardiology Devices Market, by Product Type
4.1 Introduction
       4.1.1 Global Interventional Cardiology Devices Market Revenue, by Type, 2012 – 2022 (USD Million)
4.2 Stents
       4.2.1 Global Stents Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.2.2 Bare Metal Stents
               4.2.2.1 Global Bare Metal Stents Market Revenue, 2012 – 2022(USD Million)
       4.2.3 Drug Eluting Stents (DES)
               4.2.3.1 Global Drug Eluting Stents Market Revenue, 2012 – 2022 (USD Million)
       4.2.4 Bio-absorbable Stents
               4.2.4.1 Global Bio-absorbable Stents Market Revenue, 2012 – 2022 (USD Million)
4.3 Catheters
       4.3.1 Global Interventional Cardiology Catheters Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.3.2 Angiography Catheters
               4.3.2.1 Global Angiography Catheters Market Revenue, 2012 – 2022 (USD Million)
       4.3.3 Intravascular Ultrasound (IVUS) Catheters
               4.3.3.1 Global Intravascular Ultrasound (IVUS) Catheters Market Revenue, 2012 – 2022 (USD Million)
       4.3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters
               4.3.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters Market Revenue, 2012 – 2022 (USD Million)
       4.3.5 Pulmonary Artery Catheters
               4.3.5.1 Global Pulmonary Artery Catheter Market Revenue, 2012 – 2022 (USD Million)
4.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
       4.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.4.2 Normal Balloons
               4.4.2.1 Global Normal Balloons Market Revenue, 2012 – 2022 (USD Million)
       4.4.3 Cutting Balloons
               4.4.3.1 Global Cutting Balloons Market Revenue, 2012 – 2022 (USD Million)
       4.4.4 Scoring Balloons
               4.4.4.1 Global Scoring Balloons Market Revenue, 2012 – 2022 (USD Million)
       4.4.5 Drug Eluting Balloons
               4.4.5.1 Global Drug Eluting Balloons Market Revenue, 2012 – 2022 (USD Million)
4.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires
       4.5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires Market Revenue, 2012 – 2022 (USD Million)
4.6 Other Accessories (introducer sheath systems, needles, forceps, etc.)
       4.6.1 Global Other Accessories (introducer sheath systems, needles, forceps, etc.) Market Revenue, 2012 – 2022 (USD Million)
4.7 Interventional Cardiology Systems
       4.7.1 Global Interventional Cardiology Systems Market Revenue, by Type, 2012 – 2022 (USD Million)
       4.7.2 Intravascular Ultrasound (IVUS) Systems
               4.7.2.1 Global Intravascular Ultrasound (IVUS) Systems Market Revenue, 2012 – 2022 (USD Million)
       4.7.3 Fractional Flow Reserve (FFR) System
               4.7.3.1 Global Fractional Flow Reserve (FFR) Systems Market Revenue, 2012 – 2022 (USD Million)
       4.7.4 Optical Coherence Tomography (OCT) Systems
               4.7.4.1 Global Optical Coherence Tomography (OCT) Systems Market Revenue, 2012 – 2022 (USD Million)

Chapter 5 Global Interventional Cardiology Devices Market, by Geography
5.1 Overview
       5.1.1 Global Interventional Cardiology Devices Market Revenue, by Geography, 2012 – 2022 (USD Million)
5.2 North America
       5.2.1 North America Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.3 Europe
       5.3.1 Europe Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.4 Asia-Pacific (APAC)
       5.4.1 Asia-Pacific Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.5 Latin America (LATAM)
       5.5.1 LATAM Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.6 MENA
       5.6.1 MENA Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
5.7 Rest of the World (RoW)
       5.7.1 RoW Interventional Cardiology Devices Market Revenue, 2012 – 2022 (USD Million)

Chapter 6 Recommendations
6.1 Investing in Emerging Markets of Asia Pacific, Latin America, and Africa
6.2 Focus on improved and technologically advanced interventional cardiology devices

Chapter 7 Company Profiles
7.1 Abbott Laboratories, Inc.
       7.1.1 Company Overview
       7.1.2 Financial Overview
       7.1.3 Product Portfolio
       7.1.4 Business Strategies
       7.1.5 Recent Developments
7.2 B. Braun Melsungen AG
       7.2.1 Company Overview
       7.2.2 Financial Overview
       7.2.3 Product Portfolio
       7.2.4 Business Strategies
       7.2.5 Recent Developments
7.3 Boston Scientific Corporation
       7.3.1 Company Profile
       7.3.2 Financial Overview
       7.3.3 Product Portfolio
       7.3.4 Business Strategies
       7.3.5 Recent Developments
7.4 Cook Medical, Inc.
       7.4.1 Company Overview
       7.4.2 Financial Overview
       7.4.3 Product Portfolio
       7.4.4 Business Strategies
       7.4.5 Recent Developments
7.5 Johnson & Johnson (Cordis Corporation)
       7.5.1 Company Overview
       7.5.2 Financial Overview
       7.5.3 Product Portfolio
       7.5.4 Business Strategies
       7.5.5 Recent Developments
7.6 Medtronic, Inc.
       7.6.1 Company Overview
       7.6.2 Financial Overview
       7.6.3 Product Portfolio
       7.6.4 Business Strategies
       7.6.5 Recent Development
7.7 Smiths Medical
       7.7.1 Company Overview
       7.7.2 Financial Overview
       7.7.3 Product Portfolio
       7.7.4 Business Strategies
       7.7.5 Recent Developments
7.8 St. Jude Medical, Inc.
       7.8.1 Company Profile
       7.8.2 Financial Overview
       7.8.3 Product Portfolio
       7.8.4 Business Strategies
7.9 Terumo Corporation
       7.9.1 Company Overview
       7.9.2 Financial Overview
       7.9.3 Product Portfolio
       7.9.4 Business Strategies
       7.9.5 Recent Developments

List of Figures

FIG. 1 Interventional Cardiology Devices: Market Segmentation
FIG. 2 Global Interventional Cardiology Devices Market, by Types, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Interventional Cardiology Devices Revenue, by Geography, 2013 & 2022 (Value %)
FIG. 4 The absolute number of coronary heart disease deaths by decade of age, 2010-2040
FIG. 5 Porter’s Five Forces Analysis: Global Interventional Cardiology Devices Market
FIG. 6 Market Attractiveness Analysis: Global Interventional Cardiology Devices Market, by Geography (2013)
FIG. 7 Market Share Analysis, by Key Players: Global Interventional Cardiology Devices Market, 2014 (Value %)
FIG. 8 Value Chain Analysis: Global Interventional Cardiology Devices Market
FIG. 9 Global Bare Metal Stents Market Revenue, 2012 – 2022 (USD Million)
FIG. 10 Global Drug Eluting Stents Market Revenue, 2012 – 2022 (USD Million)
FIG. 11 Global Bio-absorbable Stents Market Revenue, 2012 – 2022 (USD Million)
FIG. 12 Global Angiography Catheters Market Revenue, 2012 – 2022 (USD Million)
FIG. 13 Global Intravascular Ultrasound (IVUS) Catheters Market Revenue, 2012 – 2022 (USD Million)
FIG. 14 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters Market Revenue, 2012 – 2022 (USD Million)
FIG. 15 Global Pulmonary Artery Catheter Market Revenue, 2012 – 2022 (USD Million)
FIG. 16 Global Normal Balloons Market Revenue, 2012 – 2022 (USD Million)
FIG. 17 Global Cutting Balloons Market Revenue, 2012 – 2022 (USD Million)
FIG. 18 Global Scoring Balloons Market Revenue, 2012 – 2022 (USD Million)
FIG. 19 Global Drug Eluting Balloons Market Revenue, 2012 – 2022 (USD Million)
FIG. 20 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires Market Revenue, 2012 – 2022 (USD Million)
FIG. 21 Global Other Accessories (Introducer sheath systems, needles, forceps, etc.) Market Revenue, 2012 – 2022 (USD Million)
FIG. 22 Global Intravascular Ultrasound (IVUS) Systems Market Revenue, 2012 – 2022 (USD Million)
FIG. 23 Global Fractional Flow Reserve (FFR) Systems Market Revenue, 2012 – 2022 (USD Million)
FIG. 24 Global Optical Coherence Tomography (OCT) Systems Market Revenue, 2012 – 2022 (USD Million)
FIG. 25 RoW Interventional Cardiology Devices Market Revenue, 2012 – 2022 (USD Million)
FIG. 26 Abbott Laboratories, Inc.: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 27 B. Braun Melsungen AG: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 28 Boston Scientific Corporation: Annual Revenue, 2012 – 2014 (USD million)
FIG. 29 Johnson & Johnson: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 30 Medtronic, Inc., Annual Revenue: 2012 - 2014 (USD Million)
FIG. 31 Smiths Medical: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 32 St. Jude Medical, Inc.: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 33 Terumo Corporation: Annual Revenue, 2012 – 2014 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Interventional Cardiology Devices Market (2013 & 2022)
TABLE 2 Global Interventional Cardiology Devices Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 3 Global Stents Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 4 Global Interventional Cardiology Catheters Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 5 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 6 Global Interventional Cardiology Systems Market Revenue, by Type, 2012 – 2022 (USD Million)
TABLE 7 Global Interventional Cardiology Devices Market Revenue, by Geography, 2012 – 2022 (USD Million)
TABLE 8 North America Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 9 Europe Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 10 Asia-Pacific Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 11 LATAM Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)
TABLE 12 MENA Interventional Cardiology Devices Market Revenue, by Country, 2012 – 2022 (USD Million)

Enquiry Before Buying


Free Market Analysis



Coronary artery bypass surgery (CABG) was invented 50 years ago for the treatment of complex ischemia and multi-vessel coronary artery disease (CAD). However, CABG procedures (according to the studies conducted by the NCBI) is witnessing decline due to evolution of interventional techniques. Interventional cardiology is a minimally invasive catheter based technology that enables treatment of coronary artery disease. Minimally invasive surgeries have advantages such as shorter hospital stay, reduced cost, minimal incision, less post-surgical complications and shorter recovery time. Geriatric population and rising prevalence of coronary artery diseases are the prime reasons driving the growth of global interventional cardiology. Rising prevalence of lifestyle habits such as smoking, rising incidence of obesity, and dietary irregularities are responsible for the growth of cardiac artery disease prevalence in the world. In Europe, CAD accounts for 1.9 million deaths each year. Moreover, 1 individual in 5 (21% men, 22% women) dies from coronary artery disease in the Europe. The disorder is also one of the most common causes of premature deaths (aged <65 years) and accounts for 401,000 deaths in Europe each year. Hence, high prevalence of coronary artery diseases would increase demand for percutaneous coronary interventions (PCIs), which in turn would propel the growth of the interventional cardiology devices market. 

The global interventional cardiology devices market has been estimated based on various device types: stents, catheters, percutaneous transluminal coronary angioplasty (PTCA) balloons, percutaneous transluminal coronary angioplasty (PTCA) guide wires, and other accessories. The stents segment held the largest share of the market in 2013 which is further subdivided into bare metal stents, drug eluting stents and bio-absorbable vascular stents. Coronary stents are used for variety of coronary artery diseases including bifurcation lesions, small lesions and narrow lesions. Coronary stents have improved the clinical outcome for all the approved indications and quality life of patients. Drug eluting stents accounted for the largest market share of the overall interventional cardiology devices market in 2014 and continues to be the leader during the forecast period. The leadership of DES segment was primarily attributed to improved patient outcome as compared to bare metal stents and reduced need for repeated interventions. Rising prevalence of coronary artery disease and requirement of effective therapies for the reducing the rate of restenosis would also fuel the market growth. 

Percutaneous transluminal coronary angioplasty (PTCA) balloons have been subdivided into normal balloons, cutting balloons, scoring balloons, and drug eluting balloons. Normal balloons accounted for the largest share of PTCA balloons market and would continue to dominate the market during the forecast period as well. The growth of this segment has been attributed to the increasing volume of stents in emerging countries and first mover advantage as compared to other types of balloons. The imaging systems interventional cardiology devices market is further categorized into intravascular ultrasound (IVUS) systems, fractional flow reserve (FFR) systems, and optical coherence tomography (OCT) systems. Intravascular ultrasound (IVUS) imaging system held majority share of the market in 2013.  IVUS has emerged as an effective diagnostic tool over traditional angiography for the diagnosis of atherosclerosis. The system provides detailed cross sectional view of coronary artery and also enables optimal choice of appropriate angioplasty technique for better deployment of stents. 

Geographically, the interventional cardiology devices market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World (RoW). North America dominated the global interventional cardiology devices market followed by Europe owing to the continued adoption of premium priced drug eluting stents and rising incidence of cardiovascular diseases. Asia Pacific was the third largest market for interventional cardiology devices, the region is expected to register the fastest CAGR during the forecast period. Large untapped opportunities, improving health care infrastructure, increasing prevalence of coronary artery disease, expansion of market players, and rising geriatric population in the region would contribute to the market growth.

Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation are the major players operating in the global interventional cardiology devices market. Most of these players are constantly striving to retain or enhance their market share by developing technologically advanced products.

interventional-cardiology-devices

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research